![Rasmus Holm-Jorgensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rasmus Holm-Jorgensen
Inga fler pågående positioner
Förmögenhet: 41 741 $ per 2026-05-31
Profil
Mr. Rasmus Holm-Jorgensen was previously employed as a Chief Financial Officer by Acrivon Therapeutics, Inc., a Chief Strategy & Portfolio Officer by Kiniksa Pharmaceuticals Ltd., and a Group Vice President & General Manager by Synageva BioPharma Corp.
He received his graduate degree from the University of Copenhagen.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-03-01 | 26 088 ( 0,06 % ) | 41 741 $ | 2026-05-31 |
Tidigare kända positioner av Rasmus Holm-Jorgensen
| Företag | Position | Slut |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Finansdirektör/CFO | 2025-04-01 |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Grundare | 2022-04-01 |
| SYNAGEVA BIOPHARMA CORP | Företagsledare/Principal | 2015-01-01 |
Rasmus Holm-Jorgensens utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
28
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
![\"G](\"https://www.zonebourse.com/images/ImagesTagged/GD/2026/google/Google__G__logo.svg\"){kind=logo}
Välj MarketScreener 
